DR. AVTAR K SINGH, M.D.
Medical Practice at Bee St, Charleston, SC
License number
South Carolina 13385
Category
Medical Practice
Type
Anatomic Pathology & Clinical Pathology
Address
Address
2
109 Bee St, Charleston, SC 29401
3164 Pignatelli Cres, Mount Pleasant, SC 29466
3164 Pignatelli Cres, Mount Pleasant, SC 29466
Phone
(843) 789-7232
(843) 805-5793 (Fax)
(843) 884-3484
(843) 805-5793 (Fax)
(843) 884-3484
Professional information
Dr. Avtar K Singh, Charleston SC - MD (Doctor of Medicine)
Specialties:
Anatomic & Clinical Pathology
Address:
Charleston VA Med Ctr Pthlgy
109 Bee St SUITE MC-113, Charleston 29401
(843) 577-5011 (Phone)
MUSC Pathology
39 Albert B Sabin St SUITE RS109, Charleston 29425
(843) 792-3807 (Phone)
109 Bee St SUITE MC-113, Charleston 29401
(843) 577-5011 (Phone)
MUSC Pathology
39 Albert B Sabin St SUITE RS109, Charleston 29425
(843) 792-3807 (Phone)
Certifications:
Anatomic & Clinical Pathology, 1992
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Charleston VA Med Ctr Pthlgy
109 Bee St SUITE MC-113, Charleston 29401
MUSC Pathology
39 Albert B Sabin St SUITE RS109, Charleston 29425
Musc Medical Center
169 Ashley Ave, Charleston 29425
Roper Hospital
316 Calhoun St, Charleston 29401
109 Bee St SUITE MC-113, Charleston 29401
MUSC Pathology
39 Albert B Sabin St SUITE RS109, Charleston 29425
Musc Medical Center
169 Ashley Ave, Charleston 29425
Roper Hospital
316 Calhoun St, Charleston 29401
Methods For Treating Inflammatory Disorders
US Patent:
2009011, Apr 30, 2009
Filed:
Jun 13, 2005
Appl. No.:
11/570635
Inventors:
Inderjit Singh - Mount Pleasant SC, US
Avtar Singh - Mount Pleasant SC, US
Avtar Singh - Mount Pleasant SC, US
Assignee:
MUSC Foundation for Research Development - Charleston SC
International Classification:
A61K 31/5375, A61K 31/44, A61P 3/10
US Classification:
5142378, 514348
Abstract:
The present invention relates generally to the fields of molecular biology. More particularly, it concerns materials and methods for the treatment of nitric oxide and cytokind mediated disorders. In a preferred embodiment, PDMP may be used to inhibit the expression of iNOS and pro-inflammatory cytokines such as TNFα and IL1β.
Methods For Treating Inflammatory Disorders
US Patent:
2011005, Mar 10, 2011
Filed:
Mar 30, 2010
Appl. No.:
12/750411
Inventors:
Inderjit Singh - Mount Pleasant SC, US
Avtar Singh - Mount Pleasant SC, US
Avtar Singh - Mount Pleasant SC, US
International Classification:
A61K 31/7028, A61K 31/445, A61K 31/5375, A61K 31/4015, A61K 31/40, A61K 31/4025, A61P 25/00
US Classification:
514 25, 514315, 5142378, 514424, 514428, 514422
Abstract:
The present invention relates generally to the fields of molecular biology. More particularly, it concerns materials and methods for the treatment of nitric oxide and cytokind mediated disorders. In a preferred embodiment, PDMP may be used to inhibit the expression of iNOS and pro-inflammatory cytokines such as TNFα and IL1β.